Bräutigam M - Search Results

1

The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion.

Mrowietz U, Graeber M, Bräutigam M, Thurston M, Wagenaar A, Weidinger G, Christophers E. Mrowietz U, et al. Among authors: brautigam m. Br J Dermatol. 1998 Dec;139(6):992-6. doi: 10.1046/j.1365-2133.1998.02554.x. Br J Dermatol. 1998. PMID: 9990361 Clinical Trial.

2

An experimental ointment formulation of pimecrolimus is effective in psoriasis without occlusion.

Mrowietz U, Wustlich S, Hoexter G, Graeber M, Bräutigam M, Luger T. Mrowietz U, et al. Among authors: brautigam m. Acta Derm Venereol. 2003;83(5):351-3. doi: 10.1080/00015550310003791. Acta Derm Venereol. 2003. PMID: 14609102 Free article. Clinical Trial.

3

Terbinafine in onychomycosis with involvement by non-dermatophytic fungi.

Nolting S, Brautigam M, Weidinger G. Nolting S, et al. Among authors: brautigam m. Br J Dermatol. 1994 Apr;130 Suppl 43:16-21. doi: 10.1111/j.1365-2133.1994.tb06088.x. Br J Dermatol. 1994. PMID: 8186136

4

Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.

Tausch I, Bräutigam M, Weidinger G, Jones TC. Tausch I, et al. Among authors: brautigam m. Br J Dermatol. 1997 May;136(5):737-42. Br J Dermatol. 1997. PMID: 9205509 Clinical Trial.

5

Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The Study Group.

Hamm H, Schwinn A, Bräutigam M, Weidinger G. Hamm H, et al. Among authors: brautigam m. Br J Dermatol. 1999 Mar;140(3):480-2. doi: 10.1046/j.1365-2133.1999.02713.x. Br J Dermatol. 1999. PMID: 10233270 Clinical Trial.

6

Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study.

Thaçi D, Bräutigam M, Kaufmann R, Weidinger G, Paul C, Christophers E. Thaçi D, et al. Among authors: brautigam m. Dermatology. 2002;205(4):383-8. doi: 10.1159/000066425. Dermatology. 2002. PMID: 12444336 Clinical Trial.

7

Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin. LAGOS III Study Group.

Haneke E, Tausch I, Bräutigam M, Weidinger G, Welzel D. Haneke E, et al. Among authors: brautigam m. J Am Acad Dermatol. 1995 Jan;32(1):72-7. doi: 10.1016/0190-9622(95)90187-6. J Am Acad Dermatol. 1995. PMID: 7822520 Clinical Trial.

8

German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection.

Bräutigam M, Nolting S, Schopf RE, Weidinger G. Bräutigam M, et al. Br J Dermatol. 1996 Jun;134 Suppl 46:18-21: discussion 38. doi: 10.1111/j.1365-2133.1996.tb15654.x. Br J Dermatol. 1996. PMID: 8763463 Clinical Trial.

9

Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis. A prospective multicentre study.

Mahrle G, Schulze HJ, Bräutigam M, Mischer P, Schopf R, Jung EG, Weidinger G, Färber L. Mahrle G, et al. Among authors: brautigam m. Br J Dermatol. 1996 Nov;135(5):752-7. Br J Dermatol. 1996. PMID: 8977676 Clinical Trial.

10

Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile.

Meffert H, Bräutigam M, Färber L, Weidinger G. Meffert H, et al. Among authors: brautigam m. Acta Derm Venereol. 1997 Mar;77(2):137-41. doi: 10.2340/0001555577137141. Acta Derm Venereol. 1997. PMID: 9111826 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters